Ceragenix Pharmaceuticals has entered into an exclusive evaluation and option to license agreement with a healthcare company covering the use of the company’s Cerashield antimicrobial technology for a specific medical device associated with a high incidence of hospital acquired infection
(May 29, 2009)
WELCOME TO MDDEXEC.com
Thank you for visiting our new community of Medical Device & Diagnostics sales & marketing executives. If it's your first time, click one of these links to learn more.
Winner Medical sets up JV in China
Winner Medical Group Inc. and Chengdu Likang Industries have set up a joint venture in Chengdu to pursue medical dressing product markets opportunities in West China.
The JV has been established through Winner Medical’s wholly-owned subsidiary, Winner Industries (Shenzhen) Co., Ltd.
(May 29, 2009)Rafael Medical receives marketing clearance
Rafael Medical Technologies Ltd. has obtained marketing clearance from the U.S. Food and Drug Administration (FDA) for its SafeFlo Vena Cava Filter.
The approval is for the permanent implantation of the filter in patients at risk of pulmonary embolism; safety and effectiveness as a retrievable or temporary filter have not been established.
(May 29, 2009)Boston Scientific gets EU approval for its new offering
Boston Scientific Inc. has said that European Union regulators have approved a new system of wires used in implanted heart devices.
The company said its Endotak Reliance 4-site system has received marketing approval.
(May 29, 2009)CerviLenz raises $4m
CerviLenz Inc. has raised $4 million in the company’s initial round of venture funding. The company is a maker of a disposable device used to predict the risk of preterm birth in pregnant women.
Louisville-based Chrysalis Ventures invested in CerviLenz along with Ann Arbor, Mich.-based Arboretum Ventures.
(May 29, 2009)Making “relationship” marketing more transparent
In a crucial move, which has been described as the most stringent state effort to regulate the marketing of medical products to doctors, the Vermont legislature has passed a law requiring drug and device makers to publicly disclose all money given to physicians and other health care providers, naming names and listing dollar amounts.
(May 29, 2009)Launching New Products: Five Deadly Sins
After all the market assessments and business plans, many new products still fail to achieve commercial success. Why do so many new products fail?
Getting Strategy Right
When senior level sales people are asked: What differentiates the selling
practices of top performers vs. average performers they consistently say: The best sales people think and act strategically and the best sales managers help them learn how to do it.
ConvaTec signs deal to take its offerings to U.S. Armed Forces
ConvaTec has signed a co-promotion agreement with HemCon Medical Technologies Inc. to market ConvaTec’s advanced wound and critical care products to the U.S. Armed Forces.
(Apr 22, 2009)Massachusetts’ puts a restriction on promotional programmes
Massachusetts has reportedly issued a final regulation implementing “a sweeping new regime affecting the way biotechnology, pharmaceutical and medical device companies can market their products within the Commonwealth”.
(Apr 22, 2009)